Development of patient-friendly and safe biopsy-instrument for tissue sampling in breast cancer
Reference number | |
Coordinator | NeoDynamics AB |
Funding from Vinnova | SEK 4 000 000 |
Project duration | March 2012 - March 2013 |
Status | Completed |
Purpose and goal
The company will drive forward product development of a novel biopsy high-end biopsy device with a planned market launch end of 2013. Given the advantages of the device the company aims at reaching a substantial market share and will be able to help clinicians to provide safe and patient-friendly breast cancer care.